Arrowhead Pharmaceuticals Inc. sell StockNews.com
Start price
28.11.24
/
50%
€25.03
Target price
28.11.25
-
Performance (%)
79.22%
End price
29.11.25
€44.86
Summary
This prediction ended on 29.11.25 with a price of €44.86. The price for Arrowhead Pharmaceuticals Inc. massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -6.611% | -6.611% | 241.631% |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% |
Comments by StockNews_com for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.71
22.11.23
22.11.23
-
22.11.24
22.11.24
-32.59%
23.11.24
23.11.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.10
30.09.23
30.09.23
-
30.09.24
30.09.24
-30.14%
01.10.24
01.10.24

